...
首页> 外文期刊>Journal of Artificial Organs >Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator
【24h】

Up to 151 days of continuous animal perfusion with trivial heparin infusion by the application of a long-term durable antithrombogenic coating to a combination of a seal-less centrifugal pump and a diffusion membrane oxygenator

机译:通过将长期耐用的抗血栓形成涂层结合到无密封离心泵和扩散膜充氧器上,可对动物进行长达151天的琐碎肝素输注连续灌注

获取原文
获取原文并翻译 | 示例
   

获取外文期刊封面封底 >>

       

摘要

We developed a new coating material (Toyobo-National Cardiovascular Center coating) for medical devices that delivers high antithrombogenicity and long-term durability. We applied this coating to an extracorporeal membrane oxygenation (ECMO) system, including the circuit tube, cannulae, a seal-less centrifugal pump, and a diffusion membrane oxygenator, to realize prolonged cardiopulmonary support with trivial anticoagulant infusion. The oxygenator consisted of a hollow-fiber membrane made of polymethylpentene, which allows the transfer of gas by diffusion through the membrane. The centrifugal pump was free of seals and had a pivot bearing. We performed a venoarterial bypass in a goat using this ECMO system, and the system was driven for 151 days with trivial anticoagulant infusion. Plasma leakage from the oxygenator did not occur and sufficient gas-exchange performance was well maintained. In the oxygenator, thrombus formation was present around the top and the distributor of the inlet portion and was very slight in the outlet portion. In the centrifugal blood pump, there was some wear in the female pivot region and quite small amounts of thrombus formation on the edge of the shroud; the pivot wear seemed to be the cause of the hemolysis observed after 20 weeks of perfusion and which resulted in the termination of the perfusion. However, no significant amounts of thrombus were observed in other parts of the system. This ECMO system showed potential for long-term cardiopulmonary support with minimal use of systemic anticoagulants.
机译:我们开发了一种用于医疗器械的新型涂层材料(东洋国家心血管中心涂层),具有很高的抗血栓形成性和长期耐用性。我们将此涂料应用于体外膜充氧(ECMO)系统,包括回路管,套管,无密封离心泵和扩散膜充氧器,以实现琐碎的抗凝剂输注来延长心肺功能。充氧器由聚甲基戊烯制成的中空纤维膜组成,该膜允许气体通过扩散穿过膜而转移。离心泵无密封件,并带有枢轴轴承。我们使用此ECMO系统在山羊中进行了静脉动静脉旁路手术,并通过少量抗凝剂输注将系统驱动了151天。没有发生从充氧器的等离子体泄漏,并且充分保持了足够的气体交换性能。在充氧器中,在入口部分的顶部和分配器周围存在血栓形成,在出口部分很少。在离心式血泵中,凹形枢轴区域存在一定的磨损,并且在罩的边缘形成了少量血栓。枢轴磨损似乎是灌注20周后观察到的溶血的原因,并导致灌注终止。但是,在系统的其他部分未观察到大量血栓。这种ECMO系统显示出在最少使用全身性抗凝剂的情况下长期心肺支持的潜力。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号